Prostate cancer remains significant public health concern amid growing controversies regarding prostate specific antigen (PSA) based screening. The utility of PSA has been brought into question, and alternative measures are investigated to remedy the overdetection of indolent disease and safeguard patients from the potential harms resulting from an elevated PSA. Multiparametric MRI of the prost...

Abstract Image-guided prostate biopsies are changing the outlook of cancer (PCa) diagnosis, with degree suspicion on multiparametric magnetic resonance imaging (mp-MRI) being a strong predictor targeted biopsy outcome. It is important not only to detect these suspicious lesions but also be aware potential pitfalls in mp-MRI imaging. The aim this pictorial essay show wide spectrum representative...

Magnetic resonance imaging (MRI) has been used for staging prostate cancer (PCa) since the 1990’s, more precisely after the advent of the endorectal coil, which enabled significant improvement in the quality of the examination. Also, the standardization of prostate MRI with multiparametric sequences (including high resolution T2-weighted, diffusion and dynamic contrast-enhanced or perfusion ima...

Multiparametric magnetic resonance imaging (mpMRI) has emerged as a first-line screening and diagnostic tool for prostate cancer, aiding in treatment selection noninvasive radiotherapy guidance. However, the manual interpretation of MRI data is challenging time-consuming, which may impact sensitivity specificity. With recent technological advances, artificial intelligence (AI) form computer-aid...

Quantitative magnetic resonance imaging (MRI)-based biomarkers, which capture physiological and functional tumor processes, were evaluated as imaging surrogates of early tumor response following chemoradiotherapy in glioma patients. A multiparametric extension of a voxel-based analysis, referred as the parametric response map (PRM), was applied to quantitative MRI maps to test the predictive po...

Introduction In clinical monitoring of brain tumors, Perfusion Weighted Imaging (PWI) contributes to tumor grading and to assess the response to treatment [1]. Beyond tumor perfusion, tumor hypoxia determines the response of various therapeutic approaches including radiotherapy. All these parameters may be mapped with MRI. However, the integration of several MRI maps is difficult. This wealth o...

Imaging technologies are presently receiving considerable attention in the pharmaceutical area owing to their potential to accelerate the drug discovery and development process. One of the principal imaging modalities is magnetic resonance imaging (MRI). The multiparametric nature of MRI enables anatomical, functional and even molecular information to be obtained non-invasively from intact orga...

PURPOSE To determine the optimal combination of parameters derived from 3T multiparametric (conventional magnetic resonance imaging [MRI], diffusion-weighted [DW] and dynamic contrast-enhanced [DCE]) MRI for differentiating malignant from benign orbital lymphoproliferative disorders (OLPDs). MATERIALS AND METHODS Forty patients with OLPDs (18 benign and 22 malignant) underwent conventional 3....